Suppr超能文献

静脉注射重组组织型纤溶酶原激活剂溶栓治疗后早期卒中严重程度与失语恢复的分离。

Dissociation of severity of stroke and aphasia recovery early after intravenous recombinant tissue plasminogen activator thrombolysis.

作者信息

Kremer Christine, Kappelin Johan, Perren Fabienne

机构信息

Neurology Department, Skåne University Hospital, University of Lund, Jan Waldenström Gata 15, S-20502 Malmö, Sweden.

Neurology Department, Skåne University Hospital, University of Lund, Jan Waldenström Gata 15, S-20502 Malmö, Sweden.

出版信息

J Clin Neurosci. 2014 Oct;21(10):1828-30. doi: 10.1016/j.jocn.2014.01.010. Epub 2014 May 19.

Abstract

Clinical observation suggested to us that aphasia recovers relatively better than other deficits early after intravenous recombinant tissue plasminogen activator (IV-rtPA) treatment in stroke patients with minor deficits, while the reverse seemed the case in those with severe deficits. Retrospective analysis of acute ischemic stroke patients with aphasia admitted within 3 hours from symptom onset and treated with IV-rtPA was carried out. Stroke severity, aphasia and global neurological impairment were assessed at admission and 24 hours after thrombolysis. Improvement of aphasia (gain of ⩾ 1 point on the National Institutes of Health Stroke Scale [NIHSS] aphasia score) and global neurological improvement (gain of ⩾ 4 points on the NIHSS) were compared in minor strokes (NIHSS ⩽ 7), moderate strokes (NIHSS 8-15), and major strokes (NIH ⩾ 16). Sixty-nine of 243 stroke patients suffered from aphasia. Improvement of aphasia occurred in 7/16 minor strokes, 11/25 moderate strokes, and 7/28 severe strokes. Improvement of ⩾ 4 points on the NIHSS occurred in 3/16 minor strokes, 17/25 moderate strokes and 15/28 severe strokes. There is a significant (X(2)=4.073, p<0.05) dissociation of recovery of aphasia and that of other neurological deficits between minor versus severe strokes. This confirms the clinically suspected dissociation between a good early recovery from aphasia in minor strokes relative to recovery of other neurological deficits, as opposed to a better recovery from other neurological deficits than from aphasia in patients with severe strokes.

摘要

临床观察提示我们,在轻度神经功能缺损的卒中患者中,静脉注射重组组织型纤溶酶原激活剂(IV-rtPA)治疗后,失语症的恢复相对优于其他神经功能缺损,而在重度神经功能缺损的患者中情况似乎相反。对症状发作后3小时内入院并接受IV-rtPA治疗的急性缺血性卒中失语患者进行了回顾性分析。在入院时和溶栓后24小时评估卒中严重程度、失语症和整体神经功能缺损情况。比较了轻度卒中(美国国立卫生研究院卒中量表[NIHSS]评分≤7分)、中度卒中(NIHSS评分8 - 15分)和重度卒中(NIHSS评分≥16分)中失语症的改善情况(NIHSS失语症评分提高≥1分)和整体神经功能改善情况(NIHSS评分提高≥4分)。243例卒中患者中有69例患有失语症。16例轻度卒中中有7例失语症得到改善,25例中度卒中中有11例,28例重度卒中中有7例。NIHSS评分提高≥4分的情况在16例轻度卒中中有3例,25例中度卒中中有17例,28例重度卒中中有15例。轻度与重度卒中之间,失语症恢复与其他神经功能缺损恢复存在显著差异(X(2)=4.073,p<0.05)。这证实了临床上怀疑的情况,即轻度卒中中失语症早期恢复良好相对于其他神经功能缺损的恢复,与重度卒中患者中其他神经功能缺损的恢复优于失语症的恢复相反。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验